The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
Journal of Nuclear Medicine · 2023-11 · 64 (11) · 1676-1682
DOI: 10.2967/jnumed.123.265906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 28.09.2023. Verfasst von Alberto Signore und 18 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Department of Medical-Surgical Sciences and Translational Medicine, Faculty of Medicine and Psychology, University of Rome "Sa…. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Bacterial Infections. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
The International Atomic Energy Agency organized a technical meeting at its headquarters in Vienna, Austria, in 2022 that included 17 experts representing 12 countries, whose research spanned the development and use of radiolabeled agents for imaging infection. The meeting focused largely on bacterial pathogens. The group discussed and evaluated the advantages and disadvantages of several radiopharmaceuticals, as well as the science driving various imaging approaches. The main objective was to understand why few infection-targeted radiotracers are used in clinical practice despite the urgent need to better characterize bacterial infections. This article summarizes the resulting consensus, at least among the included scientists and countries, on the current status of radiopharmaceutical development for infection imaging. Also included are opinions and recommendations regarding current research standards in this area. This and future International Atomic Energy Agency-sponsored collaborations will advance the goal of providing the medical community with innovative, practical tools for the specific image-based diagnosis of infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Unit, Department of Medical-Surgical Sciences and Translational Medicine, Faculty of Medicine and Psychology, University of Rome "Sapienza," Rome, Italy.
- Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Radiopharmaceutical Program, Board of Radiation and Isotope Technology, Mumbai, India.
- Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
- Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University of Tübingen, Tübingen, Germany.
- College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Förderung
- NIAID NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Signore, A., Ordonez, A. A., Arjun, C., Aulakh, G. K., Beziere, N., Dadachova, E., Ebenhan, T., Granados, U., Korde, A., Jalilian, A., Lestari, W., Mukherjee, A., Petrik, M., Sakr, T., Cuevas, C. L. S., Welling, M. M., Zeevaart, J. R., Jain, S. K., & Wilson, D. M. (2023). The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection. Journal of Nuclear Medicine, 64(11), 1676-1682. https://doi.org/10.2967/jnumed.123.265906
Vancouver
Signore A, Ordonez AA, Arjun C, Aulakh GK, Beziere N, Dadachova E, et al. The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection. Journal of Nuclear Medicine. 2023;64(11):1676-1682. doi:10.2967/jnumed.123.265906
BibTeX
@article{Signore2023,
author = {Signore, Alberto and Ordonez, Alvaro A and Arjun, Chanda and Aulakh, Gurpreet Kaur and Beziere, Nicolas and Dadachova, Ekaterina and Ebenhan, Thomas and Granados, Ulises and Korde, Aruna and Jalilian, Amirreza and Lestari, Wening and Mukherjee, Archana and Petrik, Milos and Sakr, Tamer and Cuevas, Clara L Santos and Welling, Mick M and Zeevaart, Jan Rijn and Jain, Sanjay K and Wilson, David M},
title = {The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection},
journal = {Journal of Nuclear Medicine},
year = {2023},
volume = {64},
number = {11},
pages = {1676--1682},
doi = {10.2967/jnumed.123.265906}
}
EUVIMED